These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33985681)

  • 1. Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials.
    Leiter LA; Bhatt DL; McGuire DK; Teoh H; Fox K; Simon T; Mehta SR; Lev EI; Kiss RG; Dalby AJ; Bueno H; Ridderstråle W; Himmelmann A; Prats J; Liu Y; Lee JJ; Amerena J; Kosiborod MN; Steg PG;
    J Am Coll Cardiol; 2021 May; 77(19):2366-2377. PubMed ID: 33985681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
    Bhatt DL; Steg PG; Mehta SR; Leiter LA; Simon T; Fox K; Held C; Andersson M; Himmelmann A; Ridderstråle W; Chen J; Song Y; Diaz R; Goto S; James SK; Ray KK; Parkhomenko AN; Kosiborod MN; McGuire DK; Harrington RA;
    Lancet; 2019 Sep; 394(10204):1169-1180. PubMed ID: 31484629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
    Steg PG; Bhatt DL; Simon T; Fox K; Mehta SR; Harrington RA; Held C; Andersson M; Himmelmann A; Ridderstråle W; Leonsson-Zachrisson M; Liu Y; Opolski G; Zateyshchikov D; Ge J; Nicolau JC; Corbalán R; Cornel JH; Widimský P; Leiter LA;
    N Engl J Med; 2019 Oct; 381(14):1309-1320. PubMed ID: 31475798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balance of benefit and risk of ticagrelor in patients with diabetes and stable coronary artery disease according to bleeding risk assessment with the CRUSADE score: Data from THEMIS and THEMIS PCI.
    Ducrocq G; Bhatt DL; Lee JJ; Kui N; Fox KM; Harrington RA; Leiter LA; Mehta SR; Kiss RG; James S; Vinereanu D; Huber K; Andersson M; Himmelmann A; Simon T; Steg PG
    Am Heart J; 2022 Jul; 249():23-33. PubMed ID: 35321823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry.
    Abtan J; Bhatt DL; Elbez Y; Ducrocq G; Goto S; Smith SC; Ohman EM; Eagle KA; Fox K; Harrington RA; Leiter LA; Mehta SR; Simon T; Petrov I; Sinnaeve PR; Pais P; Lev E; Bueno H; Wilson P; Steg PG;
    Int J Cardiol; 2023 Jan; 370():51-57. PubMed ID: 36270493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial.
    Vogel B; Baber U; Cohen DJ; Sartori S; Sharma SK; Angiolillo DJ; Farhan S; Goel R; Zhang Z; Briguori C; Collier T; Dangas G; Dudek D; Escaned J; Gil R; Han YL; Kaul U; Kornowski R; Krucoff MW; Kunadian V; Mehta SR; Moliterno D; Ohman EM; Sardella G; Witzenbichler B; Gibson CM; Pocock S; Huber K; Mehran R
    JAMA Cardiol; 2021 Sep; 6(9):1032-1041. PubMed ID: 33991416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study.
    Bhatt DL; Fox K; Harrington RA; Leiter LA; Mehta SR; Simon T; Andersson M; Himmelmann A; Ridderstråle W; Held C; Steg PG;
    Clin Cardiol; 2019 May; 42(5):498-505. PubMed ID: 30788847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis.
    Bonaca MP; Bhatt DL; Simon T; Fox KM; Mehta S; Harrington RA; Leiter LA; Capell WH; Held C; Himmelmann A; Ridderstråle W; Chen J; Lee JJ; Song Y; Andersson M; Prats J; Kosiborod M; McGuire DK; Steg PG
    J Am Coll Cardiol; 2024 Apr; 83(17):1627-1636. PubMed ID: 38658101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ticagrelor with or without Aspirin in High-Risk Patients after PCI.
    Mehran R; Baber U; Sharma SK; Cohen DJ; Angiolillo DJ; Briguori C; Cha JY; Collier T; Dangas G; Dudek D; Džavík V; Escaned J; Gil R; Gurbel P; Hamm CW; Henry T; Huber K; Kastrati A; Kaul U; Kornowski R; Krucoff M; Kunadian V; Marx SO; Mehta SR; Moliterno D; Ohman EM; Oldroyd K; Sardella G; Sartori S; Shlofmitz R; Steg PG; Weisz G; Witzenbichler B; Han YL; Pocock S; Gibson CM
    N Engl J Med; 2019 Nov; 381(21):2032-2042. PubMed ID: 31556978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.
    Baber U; Dangas G; Angiolillo DJ; Cohen DJ; Sharma SK; Nicolas J; Briguori C; Cha JY; Collier T; Dudek D; Džavik V; Escaned J; Gil R; Gurbel P; Hamm CW; Henry T; Huber K; Kastrati A; Kaul U; Kornowski R; Krucoff M; Kunadian V; Marx SO; Mehta S; Moliterno D; Ohman EM; Oldroyd K; Sardella G; Sartori S; Shlofmitz R; Steg PG; Weisz G; Witzenbichler B; Han YL; Pocock S; Gibson CM; Mehran R
    Eur Heart J; 2020 Oct; 41(37):3533-3545. PubMed ID: 33085967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims database.
    Blin P; Darmon P; Henry P; Guiard E; Bernard MA; Dureau-Pournin C; Maizi H; Thomas-Delecourt F; Lassalle R; Droz-Perroteau C; Moore N
    Cardiovasc Diabetol; 2021 Nov; 20(1):229. PubMed ID: 34823531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.
    Serruys PW; Takahashi K; Chichareon P; Kogame N; Tomaniak M; Modolo R; Chang CC; Komiyama H; Soliman O; Wykrzykowska JJ; de Winter RJ; Ferrario M; Dominici M; Buszman P; Bolognese L; Tumscitz C; Benit E; Stoll HP; Hamm C; Steg PG; Onuma Y; Jüni P; Windecker S; Vranckx P; Colombo A; Valgimigli M
    Eur Heart J; 2019 Aug; 40(31):2595-2604. PubMed ID: 31397487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial.
    Tomaniak M; Chichareon P; Klimczak-Tomaniak D; Takahashi K; Kogame N; Modolo R; Wang R; Ono M; Hara H; Gao C; Kawashima H; Rademaker-Havinga T; Garg S; Curzen N; Haude M; Kochman J; Gori T; Montalescot G; Angiolillo DJ; Capodanno D; Storey RF; Hamm C; Vranckx P; Valgimigli M; Windecker S; Onuma Y; Serruys PW; Anderson R
    Clin Res Cardiol; 2020 Jul; 109(7):930-943. PubMed ID: 31925529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease.
    Bansilal S; Bonaca MP; Cornel JH; Storey RF; Bhatt DL; Steg PG; Im K; Murphy SA; Angiolillo DJ; Kiss RG; Parkhomenko AN; Lopez-Sendon J; Isaza D; Goudev A; Kontny F; Held P; Jensen EC; Braunwald E; Sabatine MS; Oude Ophuis AJ
    J Am Coll Cardiol; 2018 Feb; 71(5):489-496. PubMed ID: 29406853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial).
    Ten Berg JM; Steg PG; Bhatt DL; Hohnloser SH; de Veer A; Nordaby M; Miede C; Kimura T; Lip GYH; Oldgren J; Cannon CP;
    Am J Cardiol; 2020 Mar; 125(5):735-743. PubMed ID: 31924322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial.
    Gao C; Tomaniak M; Takahashi K; Kawashima H; Wang R; Hara H; Ono M; Montalescot G; Garg S; Haude M; Slagboom T; Vranckx P; Valgimigli M; Windecker S; van Geuns RJ; Hamm C; Steg PG; Onuma Y; Angiolillo DJ; Serruys PW
    Cardiovasc Diabetol; 2020 Oct; 19(1):179. PubMed ID: 33066794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial.
    Krucoff M; Spirito A; Baber U; Sartori S; Angiolillo DJ; Briguori C; Cohen DJ; Collier T; Dangas G; Dudek D; Escaned J; Gibson CM; Han YL; Huber K; Kastrati A; Kaul U; Kornowski R; Kunadian V; Vogel B; Mehta SR; Moliterno D; Sardella G; Shlofmitz RA; Sharma S; Steg PG; Pocock S; Mehran R
    Am Heart J; 2024 Jun; 272():11-22. PubMed ID: 38458371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention.
    Angiolillo DJ; Baber U; Sartori S; Briguori C; Dangas G; Cohen DJ; Mehta SR; Gibson CM; Chandiramani R; Huber K; Kornowski R; Weisz G; Kunadian V; Oldroyd KG; Ya-Ling H; Kaul U; Witzenbichler B; Dudek D; Sardella G; Escaned J; Sharma S; Shlofmitz RA; Collier T; Pocock S; Mehran R
    J Am Coll Cardiol; 2020 May; 75(19):2403-2413. PubMed ID: 32240760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial.
    Steg PG; Bhatt DL; James SK; Darlington O; Hoskin L; Simon T; Fox KM; Leiter LA; Mehta SR; Harrington RA; Himmelmann A; Ridderstråle W; Andersson M; Bueno H; De Luca L; Tank A; Mellström C; McEwan P
    Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 8(8):777-785. PubMed ID: 35488865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Net Clinical Benefit Between Clopidogrel and Ticagrelor Following Percutaneous Coronary Intervention in Patients in China With Acute Coronary Syndrome.
    Li D; Sun Y; Ye X; Li L; Chen Y; Wang D
    Adv Ther; 2022 Jan; 39(1):754-766. PubMed ID: 34904209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.